期刊文献+

MicroRNA-146a在脓毒症髓源抑制细胞中的表达及其意义 被引量:4

Expression of microRNA-146a in myeloid derived suppressor cells and its significance
原文传递
导出
摘要 目的比较脓毒症3和7 d的髓源抑制细胞(MDSC)表型差异,了解其与MDSC增殖活性及免疫功能变化间的关系,通过检测MDSC中微小RNA-146a(microRNA-146a,miR-146a)的表达,探讨miR-146a对脓毒症MDSC免疫抑制活性的影响。方法采用盲肠穿孔结扎技术制备C57BL/6J小鼠脓毒症模型,运用磁珠分选方法收集分离CLP后3和7 d时小鼠骨髓MDSC(CD11b+Gr1+细胞),然后进行体外培养并给予脂多糖(LPS)刺激,收集细胞培养上清液,并检测3和7 d时分泌的细胞因子(TNF-α、TGF-β、IL-6、IL-10)和精氨酸酶活性,以及检测对T细胞的抑制作用与miR-146a的表达。结果 CLP后3 d时MDSC以分泌促炎因子(TNF-α、IL-6)为主,CLP后7 d时以分泌抗炎因子(IL-10、TGF-β)为主。CLP后7 d比3 d时表现出更强的T细胞免疫抑制活性。qRT-PCR检测小鼠骨髓MDSC中miR-146a表达,发现CLP 7 d时比3 d时的miR-146a表达量显著升高(P<0.05)。结论在脓毒症的进展过程中,MDSC表型随之发生演变,脓毒症晚期MDSC免疫抑制活性较早期显著增强。miR-146a表达上调可能是脓毒症后期MDSC免疫抑制活性增强的重要机制。 Objective To compare the phenotype of myeloid derived suppressor cells( MDSCs) separated from the bone marrow of mice 3 d and 7 d after cecal ligation and puncture( CLP) and to elucidate its potential role in the accumulation and immuno-function of MDSCs by determining the expression of microRNA-146a( miR-146a) in order to explore the effect of miR-146 a on immonosuppression of MDSCs in sepsis. Methods A septic model was prepareol by CLP in adult male C57 BL /6J mice. MDSCs( expressing cell-surface CD11 b and GR-1 antigens) from bone marrow were harvested 3 and 7days after CLP and were separated with magnetic bead sorting technique. Then,cytokines secretion and arginase-I activity were detected and the T cell proliferation in vitro and the expression of miR-146 a of MDSCs( 3 d and 7 d after CLP) were observed. Results MDSCs secreted mostly such promoting inflammatory factors as TNF-α,IL-6 3 days after CLP,but 7days after CLP,they primarily secreted IL-10 and TGF-β which were anti-inflammatory factors. MDSCs had potent immunosuppressive properties by increasing T cell suppression in a late anti-inflammatory phase( CLP3 d vs CLP7 d,P〈0. 05). In the meantime,miR-146 a of the MDSCs in bone marrow was overexpressed in septic mice at 7 days( P〈0. 05).Moreover,the expression of miR-146 a of the MDSCs in bone marrow of septic mice was higher at 7 days than at 3 days after CLP( P〈0. 05). Conclusion The data indicate that the phenotype of MDSCs evolves through early pro-inflammatory phase into the late anti-inflammatory phase. MDSCs have potent immunosuppressive properties in the late phase of sepsis.miR-146 a might play a crucial role in the regulation of immunosuppressive activity of MDSCs in late sepsis.
出处 《军事医学》 CAS CSCD 北大核心 2016年第3期217-220,225,共5页 Military Medical Sciences
关键词 髓源抑制细胞 microRNA-146a 脓毒症 免疫抑制 细胞因子类 myeloid-derived suppressor cells miR-146a sepsis immunosuppression cytokines
  • 相关文献

参考文献19

  • 1Gabrilovich DI, Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system[ J]. Nat Rev Immunol,2009, 9 (3) : 162 -174.
  • 2Kao J, Ko EC, Eisenstein S, et al. Targeting immune suppress- ing myeloid-derived suppressor cells in oneology [ J ]. Crit Rev Oncol Hematol,2011,77( 1 ) : 12 - 19.
  • 3Reid G, Kirschner MB, van Zandwijk N. Circulating micro- RNAs: association frith disease and potential .use as biomarkers [J]. Crit Rev Oneol Hematol,2011, 80(2): 193 -208.
  • 4Tsitsiou E, Lindsay MA. MicroRNAs and the immune response [J]. Curr Opin Pharmaeol,2009, 9(4) : 514 -520.
  • 5Bronte V, Zanovello P. Regulation of immune responses by L-ar- ginine metabolism[ J]. Nat Rev Immunol,2005, 5 (8) : 641 - 654.
  • 6Solito S, Bronte V, Mandruzzato S. Antigen specificity of im- mune suppression by myeloid-derived suppressor cells [ J ]. J Leukoc Biol,2011, 90(1): 31-36.
  • 7Taganov KD, Boldin MP, Chang KJ, et al. NF-kappaB-Depend- ent induction of microRNA miR-146, an inhibitor targeted to sig- naling proteins of innate immune responses [ J ]. Proe Natl Acad Sci USA, 2006, 103(33): 12481-12486.
  • 8Kao J, Ko EC, Eisenstein S, et al. Targeting immune suppress- ing myeloid-derived suppressor" cells in one01ogy [ J ]. Crit aev Oncol Hematol,2011, 77( 1 ) : 12 - 19.
  • 9Lyons A, Goebel A, Mannick JA, et al. Protective effects of ear- ly interleukin 10 antagonism on injury-induced immune dysfunc- tion[J]. Arch Surg,1999, 134(12) : 1317 -1323, 1324.
  • 10Biffl WL, Moore EE, Moore FA, et al. Interleukin-6 in the in- jured patient. Marker of injury or mediator of inflammation[J] ? Ann Surg,1996, 224(5) : 647 -664.

同被引文献29

引证文献4

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部